Incyte Corporation (NASDAQ:INCY) surged +2.23% and closed the trade at $ 82.15. The company recorded a trading capacity of 1.46 million shares above its three months average daily volume of 1.13 million shares. During the last trade, shares reached to high price of $82.57 and touched the low price of $79.75. The stock’s 50-day moving average is noted at $83.23 and its 200-day moving average is stands at $78.45.
Additionally, the company has a PE ratio of 223.23 and has EPS of 0.37. The company has market capitalization of $15.44B.
Currently Incyte Corporation (INCY) captured an average recommendation of “ Buy ” from analysts, according to FactSet data. The stock has been suggested as “Buy” from “17″ Analysts”. “0” rated “Sell” for the company. “2” said the company as a “Hold”. Overweight rating was given by “0” and Underweight rating was given by “0”.
Analysts are expecting that the company to achieve $98.13 Price Target in next 52-weeks, average price is come up through the consensus of analysts. High potential price target is set at $106.00 however minimum price target advised by analysts is $87.00. The Median price target for the stock is measured at $99.50.
Presently, Analysts decided consensus EPS estimate of $-0.04 for present quarter and one month ago projected EPS estimate was at $-0.04. If we take a look at back 3 month ago, consensus EPS estimate was $-0.05.
A current consensus EPS estimate for next quarter is at $-0.10 and 3 month ago EPS forecast was $-0.08. Have a look at back 1 month ago, consensus EPS forecast was seen at $-0.10.
For current fiscal year, most recent EPS estimate is set at $0.17 based on Analyst consensus and three month ago consensus EPS opinions was at $0.07. During period one month ago, consensus EPS forecast was decided at $0.17.
A current consensus EPS projection for next fiscal year is observed at $1.35 and one month ago consensus EPS forecast was at $1.35. Take a look at back three month ago, consensus EPS estimate opinions was decided at $1.27 by analysts.
One Month ago, the stock has gained consensus mean rating of Buy based on the analysis of brokerage analyst firms polled. 17 presented the recommendations about the stock as a “Buy” signal and “Overweight” signal was reported by 0. 2 advised the “Hold” rating about this stock. 0 revealed “Sell” signal and “Underweight” rating was declared by 0.
Three Months Ago, Analysts recommended an average brokerage rating of Buy derived from brokerage firms, according to FactSet. 15 said a “Buy Rating” and 0 announced “Overweight Rating”. 2 advised “Hold Rating” regarding the stock. 0 announced “Sell Rating” and 0 disclosed “Underweight Rating”.